A Phase 3, Randomized, Double-Blind, Comparative Trial of Micafungin Versus Fluconazole for the Treatment of Esophageal Candidiasis

Trial Profile

A Phase 3, Randomized, Double-Blind, Comparative Trial of Micafungin Versus Fluconazole for the Treatment of Esophageal Candidiasis

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Apr 2014

At a glance

  • Drugs Micafungin (Primary) ; Fluconazole
  • Indications Oral candidiasis
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 08 Apr 2014 Profile updated from Antimicrobial Agents and Chemotherapy.
    • 08 Apr 2014 Planned number of patients changed to 523.
    • 08 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top